glp 1 and atrial fibrillation Impact of GLP-1 Receptor Agonist Therapy on Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis Impact of GLP-1 Receptor Agonist

Description

There might be room for two titans in the obesity business, but a third player might have a uniquely marketable option.

"Like the practical insights and info, as usual from Old Bull"

However, genetic variants can alter the response in some.

Called Foundayo, the tablet becomes the second one to receive FDAs green light after Novo Nordisks Wegovy

Read the full article: At the Heart of Hormonal Healthcare #Menopause #WeightLoss #GLP1 #ObesityMedicine #Women'sHealth #MenopauseCare #MetabolicHealth #HormoneHealth #WeightManagement #HealthyAgeing #EvidenceBasedMedicine #LifestyleMedicine #Dietitian #Healthcare #MidlifeHealth #MenopauseSupport #HormoneTherapy #Women'sWellbeing #TheMenopauseConsortium